Immunological effects of the anti-programmed death-1 antibody on human peripheral blood mononuclear cells.


Immune checkpoint antibody-mediated blockade has gained attention as a new cancer immunotherapy strategy. Accumulating evidence suggests that this therapy imparts a survival benefit to metastatic melanoma and non-small cell lung cancer patients. A substantial amount of data on immune checkpoint antibodies has been collected from clinical trials; however… (More)
DOI: 10.3892/ijo.2016.3586


9 Figures and Tables

Slides referencing similar topics